Healthcare / Medical Care FacilitiesSES
$0.05
+0.01 (+40.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-6.5M · quality 69.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$19M
P/E
N/A
•EV/EBITDA
N/A
•ROE
70.4%
↑Gross Margin
-1.2%
↓Debt/Equity
-0.22
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+22.6%
FCF CAGR
—
FCF margin
-90.1%
FCF / Net income
1.03x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.4M · net income $-3.9M · FCF $-4.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.4M | $4.4M | $1.8M | $1.9M | $2.4M |
| Net Income | $-3.9M | $-3.9M | $-5.3M | $-7.2M | $-4.3M |
| EBITDA | $-3.7M | $-3.7M | $-4.7M | $-6.2M | $-3.5M |
| EPS | -0.02 | -0.02 | -0.04 | -0.08 | -0.08 |
| Gross Margin | -1.2% | -1.2% | -11.5% | 7.9% | 3.9% |
| Operating Margin | -84.9% | -84.9% | -275.5% | -349.7% | -241.5% |
| Net Margin | -87.3% | -87.3% | -289.8% | -370.3% | -179.2% |
| Balance Sheet | |||||
| Debt/Equity | -0.22 | -0.22 | -0.98 | -0.42 | -0.40 |
| Current Ratio | 0.16 | 0.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.0M | $-4.0M | $-6.5M | $-6.8M | $-2.3M |
| Returns | |||||
| ROE | 70.4% | 70.4% | 335.5% | 78.0% | 49.4% |
| Growth & Yield | |||||
| Revenue Growth | 139.9% | 139.9% | -5.2% | -19.1% | — |
| EPS Growth | 38.0% | 38.0% | 55.9% | -10.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+600.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.04 → -0.02
Residual
+600.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.